We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Home CompaniesHempfusion Wellness Inc

Hempfusion Wellness Inc

Healthcare Drug Manufacturers - Specialty & Generic
PortfolioPortfolio WatchlistWatchlist
Company price
0.0 USD 0.00(0%)
Last update at 2026-11-11T21:00:00Z
VOLUME
600
Market Cap
0.00M

Momentum Score

…

Hempfusion Wellness Inc., a health and wellness supplement company, offers CBD and probiotic products in the United States. It provides tinctures, capsules, gummies, and topical creams and gel products. The company offers its products under the HempFusion, Sagely Naturals, and Apothecanna brands in approximately 18,000 retail stores in the United States and internationally. It company sells its products through its e-commerce websites. Hempfusion Wellness Inc. is based in Colorado, Denver.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
-
Low
-
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

HempFusion Wellness Inc sells hemp-derived CBD supplements, pet products and topical personal-care items primarily in the U.S. through e-commerce and retail channels. Long-term growth may be driven by rising wellness demand, product and distribution expansion, and regulatory clarity; investors may find the company attractive for its branded portfolio and scaling potential.
Key risks include regulatory and legal uncertainty for hemp-derived CBD, intense competition from larger CPG and informal sellers, limited liquidity and disclosure as an OTC Pink issuer, and variable financial performance.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
-
Dividend Yield
-
Revenue TTM
6.26M
Revenue Per Share
0.05
Gross Profit TTM
1.69M
Debt / Equity
-0.06
ROE
-200.91%
Net Debt
-9.04M
ROCE
-260.53%
Diluted EPS TTM
-0.04

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax - - -37.96M -12.15M -1.57M
Net income - - -37.96M -12.15M -1.57M
Selling general administrative - - 11.14M 5.75M 1.32M
Selling and marketing expenses - - 7.53M 6.70M 0.57M
Gross profit - 9.02M 0.40M 0.61M 0.49M
Reconciled depreciation - - 0.63M 0.28M 0.01M
Ebit - 8.78M -19.11M -13.04M -1.44M
Ebitda - 9.02M -18.48M -12.76M -1.43M
Depreciation and amortization 0.23M 0.24M 0.63M 0.28M 0.01M
Operating income - 9.02M -19.29M -12.29M -1.42M
Other operating expenses - - 22.97M 15.22M 2.62M
Interest expense - - 0.04M 0.02M 0.13M
Tax provision - - 0.00M - -
Net interest income - - -0.11M -1.05M -0.13M
Income tax expense - - 0.14M 0.21M 0.11M
Total revenue - 9.02M 3.82M 3.02M 1.21M
Total operating expenses - - 19.54M 12.82M 1.91M
Cost of revenue - - 3.42M 2.40M 0.71M
Total other income expense net - - -18.70M 1.10M -0.02M
Net income from continuing ops - - -37.96M -12.15M -1.57M
Net income applicable to common shares - - -37.96M -12.15M -1.57M
Breakdown 2020-12-31 2019-12-31 2018-12-31 2017-12-31 2016-12-31
Type yearly yearly yearly yearly yearly
Date 2020-12-31 2019-12-31 2018-12-31 2017-12-31 2016-12-31
Total assets 14.36M 38.62M 3.55M 1.56M 0.78M
Intangible assets - 6.60M - - -
Other current assets 1.53M 1.78M 1.06M 1.06M 0.36M
Total liab 17.89M 7.72M 0.38M 2.35M 0.45M
Total stockholder equity -3.54M 30.90M 3.17M -0.79M 0.33M
Other current liab 13.98M 2.51M 0.14M 0.29M 0.08M
Common stock 45.00M 45.00M 1.45M 1.45M 1.45M
Capital stock 45.00M 45.00M 6.74M - -
Retained earnings -53.92M -15.96M -3.81M -2.24M -1.12M
Other liab - 1.40M - - -
Good will 0.00M 1.11M - - -
Cash 9.26M 26.26M 1.27M 0.11M 0.07M
Total current liabilities 17.73M 6.11M 0.38M 2.35M 0.45M
Current deferred revenue 1.37M 1.72M - 0.01M 0.01M
Net debt -9.04M -25.97M -1.27M 1.72M 0.17M
Short term debt 0.06M 0.08M - 1.83M 0.25M
Short long term debt - - - 1.83M -
Short long term debt total 0.23M 0.29M - 1.83M 0.25M
Other stockholder equity 5.38M 1.85M 0.25M - -
Property plant equipment 0.53M 0.42M 0.02M 0.02M 0.01M
Total current assets 13.83M 30.49M 3.53M 1.54M 0.77M
Net tangible assets -3.54M 23.19M -2.11M -0.79M 0.33M
Net receivables 0.46M 0.67M 0.41M 0.14M 0.04M
Inventory 2.58M 1.77M 0.79M 0.24M 0.29M
Accounts payable 2.32M 1.80M 0.24M 0.23M 0.12M
Non current assets total 0.53M 8.13M 0.02M 0.02M 0.01M
Capital lease obligations 0.23M 0.29M - - -
Breakdown 2021-12-31 2020-12-31 2019-12-31 2018-12-31 2017-12-31
Type yearly yearly yearly yearly yearly
Date 2021-12-31 2020-12-31 2019-12-31 2018-12-31 2017-12-31
Investments - -2.02M -4.45M -0.01M -0.01M
Change to liabilities - 0.53M 1.43M 0.05M 0.11M
Total cashflows from investing activities - -2.02M -4.45M -0.01M -0.01M
Net borrowings - -0.09M -0.18M 0.18M 1.64M
Total cash from financing activities - -0.11M 41.15M 3.37M 1.64M
Change to operating activities - 0.25M -0.72M -0.00M -0.70M
Net income - -37.96M -12.15M -1.57M -1.12M
Change in cash - -17.00M 24.99M 1.17M 0.03M
Begin period cash flow 9.26M 26.26M 1.27M 0.11M 0.07M
End period cash flow 9.26M 9.26M 26.26M 1.27M 0.11M
Total cash from operating activities - -14.86M -11.71M -2.20M -1.59M
Issuance of capital stock - 0.00M 41.33M 3.04M -
Depreciation - 0.63M 0.28M 0.01M 0.00M
Dividends paid - 0.00M - - -
Change to inventory - -0.80M -0.58M -0.55M 0.05M
Change to account receivables - 0.14M -0.18M -0.27M -0.10M
Other cashflows from financing activities - -0.03M -0.13M 0.33M 1.64M
Change to netincome - 22.35M 0.23M 0.13M 0.16M
Capital expenditures 0.00M 0.25M 0.10M 0.01M 0.01M
Change in working capital - 0.11M -0.05M -0.77M -0.63M
Stock based compensation - 3.52M 0.13M - -
Other non cash items - 0.04M 0.01M 0.13M 0.16M
Free cash flow - -15.11M -11.81M -2.21M -1.60M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
MKKGY
Merck KGaA ADR		 -0.74
2.19%		 33.06 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 -
-%		 170.05 24.86 15.11 3.13 1.98 3.08 18.89
TAK
Takeda Pharmaceutical Co Ltd ADR		 0.34
1.66%		 21.18 - 10.96 0.01 1.20 2.94 23.11
TKPHF
Takeda Pharmaceutical Co. Ltd.		 -
-%		 41.72 - 10.66 0.01 1.16 2.94 23.11

Profile*

Hempfusion Wellness Inc

Hempfusion Wellness Inc., a health and wellness supplement company, offers CBD and probiotic products in the United States. It provides tinctures, capsules, gummies, and topical creams and gel products. The company offers its products under the HempFusion, Sagely Naturals, and Apothecanna brands in approximately 18,000 retail stores in the United States and internationally. It company sells its products through its e-commerce websites. Hempfusion Wellness Inc. is based in Colorado, Denver.

1550 Larimer Street, Denver, CO, United States, 80202

877 669 4367

https://www.hempfusion.com

47

Name Title Year Born
Dr. Jason Mitchell Co-Founder, CEO, Pres & Director 1972
Mr. Ian DeQueiroz Co-Founder, Chief of Brand Strategy & Partnerships and Director 1985
Ms. Maria Leal Chief Financial Officer NA
Mr. Jonathan Visser Chief Operating Officer 1973
Mr. G. Scott Greenburg Corp. Sec., Chief Legal Officer, Gen. Counsel, Managing Partner & Director 1956
Ms. Ola Lessard Chief Marketing Officer 1969
Mr. Daniel Brody Chief Corp. Officer NA
Mr. Daniel Brody Chief Corporate Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

DAR
GBX 8.30
+23.42%
VTY
GBX 276.20
+8.23%
GTCO
GBX 0.09
+6.98%
GLV
GBX 2.34
+6.36%
BUR
GBX 249.20
+5.95%
TMI
GBX 0.72
-6.49%
HSBA
GBX 1291.40
-5.42%
RKT
GBX 5218.00
-4.85%
TGA
GBX 643.00
-4.03%
RKH
GBX 61.70
-3.89%

Equity Sectors*

  • Basic Materials

    -1.70%

  • Communication Services

    +0.33%

  • Consumer Cyclical

    +0.45%

  • Consumer Defensive

    -0.56%

  • Energy

    -0.25%

  • Financial Services

    +0.49%

  • Healthcare

    +0.20%

  • Industrials

    +0.74%

  • Real Estate

    +1.71%

  • Technology

    -2.81%

  • Utilities

    +0.28%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Cookies on this website

We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.

Essential cookies

These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.

Analytics cookies

We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.

Marketing cookies

These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.

Support

Hi! How can we help you today?

Loading…